Regulatory compliance and e-learning company Zenosis is continuing to marry industry expertise with international commercial flair, appointing Dr Francisco Harrison as a Non-Executive Director. The company which committed 2 years to product development is now entering a phase of ambitious growth, taking orders from some of the leading lights of the Life Sciences sector in the first five weeks of 2005, equivalent to its entire turnover last year.

Dedicated to providing high quality, 'always up-to-date', resources for Life Science professionals in a boundaryless marketplace, the heavyweight board at Zenosis, felt that Dr Harrison's commercial insight in to the drug development process, and his universally recognised academic and training expertise was a natural fit for the business at such a critical stage in its development.

Graduating as an MD from the Grado de Doctorado en medicina Universidad Complutense, Madrid, Spain, Dr Harrison's roles as Lecturer at the Universitat Witten/Herdecke,Witten, Germany and author of over 60 scientific and professional publications have reinforced his universally acclaimed academic and communications credentials.

Yet, it was his ability to apply this deep understanding of the sector to business which has seen him build Harrison Clinical Research (HCR), as a leader in the field of Clinical development and registration of new pharmaceutical products and devices from phase 1 through to phase 4 as its Chairman and CEO. It was this unique balance of leadership skills that attracted Zenosis.

Says Simon Burgess, 'The Zenosis proposition, is about making the life of regulatory Life Science professionals as easy as possible in a challenging commercial and regulatory environment. Working with someone of Dr. Francisco Harrison's calibre sets the tone for us in to the future, as we build lasting relationships founded on quality, expertise and trust with some of the brightest stars in the Life Sciences industry.'